Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Fast Diagnostic Tool Investigated for Wound Infections

By HospiMedica International staff writers
Posted on 29 Aug 2011
A novel concept for a fast diagnostic tool for wound infection based on enzymes triggered release of dye from a polymeric matrix has been investigated.

For the development of a simple diagnostic tool, a liquid lysozyme assay was adapted to a solid system and the matrix consisted of alginate/agarose and peptidoglycan covalently labeled with Remazol brilliant blue. More...


Scientists from the Graz University of Technology (Austria) collected wound fluid from 10 postoperative wounds, 8 decubitus ulcer wounds, and 8 blisters and analyzed by biochemical techniques. The detection of wound infection was based on lysozyme and elastase triggered release of the dye from a peptidoglycan matrix. Incubation of 8% labeled agarose/peptidoglycan blend layers with infected wound fluid samples for two hours at 37 °C resulted in a four-fold higher amount of dye released than measured for noninfected wounds. Lysozyme activity in postoperative wounds and decubitus (bed sore) wound fluids was significantly elevated upon infection (4,830 ± 1,848 U/mL), compared to noninfected wounds (376 ± 240 U/mL).

A seven-fold higher amount of dye was released in case of infected wound fluid samples compared to noninfected ones using an alginate/peptidoglycan beads assay. By using Western blotting techniques, proteases including the gelatinase matrix metalloproteinases MMP-2 and MMP-9, and elastase were detected in wound fluids. A slight synergistic effect was measured by dye release for peptidoglycan hydrolysis, between lysozyme and these proteases. Incubation of a double-layer system consisting of stained and nonstained peptidoglycan with infected wound fluids resulted in a color change from yellow to blue, thus allowing simple visual detection of wound infection.

The authors concluded that such a diagnostic tool would allow early intervention with suitable treatment and could reduce clinical intervention and the use of antibiotics. The tool is based on human enzymes, which can be detected in wound fluid samples in a very fast way and which were shown to be elevated in case of infection. The study was published in September 2011, in the journal Diagnostic Microbiology and Infectious Disease.

Related Links:

Graz University of Technology





Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.